As the industry moves towards a more integrated and diversified vaccine ecosystem, GeoVax’s MVA-based vaccines should provide a scalable, durable, and globally accessible solution that enhances the ...

Recent Studies Support Diversified Vaccine Strategies, Aligning with GeoVax's MVA-Based GEO-CM04S1 for Enhanced Protection, ...

The vaccine contract manufacturing market is expanding rapidly, driven by rising global demand for immunization and a growing emphasis on preventive ...

The ChAdOx1 viral vector was developed at the University of Oxford and has been investigated as a potential vector for ...

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...

Brazilian researchers have developed a simple test that almost instantly tells whether a person has been exposed to any of ...

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics ...

The Philippine Pediatric Society advocates for the approval of a next-generation dengue vaccine to combat the rising dengue cases in the Philippines, highlighting its safety and effectiveness compared ...

The Welsh government has approved the emergency use of three bluetongue vaccines from 1 March this year to help slow the ...

Vaccitech's six products are all in early stage trials or pre-clinical testing, and are all based on the viral vector vaccine technology. The vaccines can be used as treatment or prophylaxis ...

Bluetongue has more of a devastating impact on livestock as it can be spread from animal to animal, and it kills adult ...